FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology and gynaecology, and concerns treating ovarian cancer. That is ensured by indole-3-carbinol injection in daily dose of 400 mg and more. Administration of preparation is started for 7-14 days before surgical intervention in extent of hysterectomy with appendages and subtotal resection of greater omentum with additional regional lymphadenectomy of pelvic and para-aortic lymph nodes. Introduction of indole-3-carbinol is continued in above dose for life and is carried out continuously or by 6-month courses with interval of 1 month.
EFFECT: method ensures extension of five-and recurrence-free survival and fewer chemoresistant forms of disease.
3 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CERVICAL CANCER USING CHEMOEMBOLISATION OF UTERINE ARTERIES WITH PLATINUM DRUGS | 2015 |
|
RU2583144C1 |
| PHARMACEUTICAL COMPOSITION FOR ADENOMYOSIS TREATMENT AND PREVENTION | 2009 |
|
RU2406497C1 |
| PHARMACEUTICAL FORMULATION FOR METASTASIS PREVENTION AND INCREASING OF TUMOUR SENSITISATION TO CHEMOTHERAPEUTIC AGENTS | 2007 |
|
RU2328282C1 |
| METHOD OF TREATING POLYCYSTIC OVARIAN SYNDROME IN ADOLESCENT GIRLS WITH USE OF NON-HORMONAL PREPARATIONS | 2014 |
|
RU2563181C1 |
| METHOD OF SURGICAL TREATMENT OF PATIENTS WITH ADVANCED OVARIAN CANCER | 2018 |
|
RU2685465C1 |
| METHOD FOR COMBINED ORGAN-PRESERVING TREATMENT OF INVASIVE CERVICAL CANCER STAGE IB-II | 2020 |
|
RU2748904C1 |
| METHOD FOR THE TREATMENT OF PERITONEAL CARCINOMATOSIS IN OVARIAN CANCER | 2021 |
|
RU2745478C1 |
| METHOD FOR COMBINED NEOADJUVANT POLYCHEMOTHERAPY OF CERVICAL CANCER PATIENTS | 2015 |
|
RU2595855C1 |
| METHOD FOR PREDICTING THE PROGRESSION OF CERVICAL CANCER IN PATIENTS WITH STAGE IIB | 2022 |
|
RU2789500C1 |
| METHOD FOR PREDICTING EARLY RECURRENCE OF CLEAR CELL CARCINOMA OF THE UTERINE BODY | 2022 |
|
RU2784775C1 |
